Back
Phathom Pharmaceuticals Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
38
PHAT
Phathom Pharmaceuticals
Last Price:
$9.02
Seasonality Move:
13.73%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
The current trend is moderately bullish and PHAT is experiencing slight buying pressure.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.36 | Sell |
| 20-day SMA: | 9.4 | Sell |
| 50-day SMA: | 6.02 | Buy |
| 200-day SMA: | 8.78 | Buy |
| 8-day EMA: | 9.26 | Sell |
| 20-day EMA: | 8.74 | Buy |
| 50-day EMA: | 7.18 | Buy |
| 200-day EMA: | 7.77 | Buy |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 57.38 | Buy |
| Chaikin Money Flow: | 345483 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Phathom Pharmaceuticals Technical Analysis
| Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 8.92 while PHAT 8-day simple moving average is 9.36, which is a Sell signal.
-
The stock price of PHAT is 8.92 while Phathom Pharmaceuticals 20-day SMA is 9.40, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 6.02 while PHAT share price is 8.92, making it a Buy technically.
-
PHAT stock price is 8.92 and Phathom Pharmaceuticals 200-day simple moving average is 8.78, creating a Buy signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
38
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $8.92. The Score for PHAT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
622.7M
Price in USD:
8.92
Share Volume:
499.1K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
2.21
Sell
38
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 8.92 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 8.92 while PHAT 8-day exponential moving average is 9.26, which is a Sell signal.
-
The stock price of PHAT is 8.92 while Phathom Pharmaceuticals 20-day EMA is 8.74, which makes it a Buy.
-
Phathom Pharmaceuticals 50-day exponential moving average is 7.18 while PHAT share price is 8.92, making it a Buy technically.
-
PHAT stock price is 8.92 and Phathom Pharmaceuticals 200-day simple moving average is 7.77, creating a Buy signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.29 per share, an increase this year of $1.78 per share, and an increase next year of $2.34 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is 0.9, suggesting Phathom Pharmaceuticals is a Buy
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 57.38, which suggest Phathom Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is ( - ), which suggest Phathom Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is ( - ), which suggest Phathom Pharmaceuticals is a Buy
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.